A/Prof Matthew Ku
Clinical (Associate Professor)
Department of Medicine
142 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trial.
DOI: 10.1016/S0140-6736(26)00866-42026
Journal article
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.
DOI: 10.1200/JCO-26-009472026
Journal article
Glofitamab plus gemcitabine and oxaliplatin for relapsed/refractory DLBCL: 3-year follow-up of STARGLO.
DOI: 10.1182/bloodadvances.20260197642026
Journal article
Safety and efficacy of Azer-cel, an allogeneic CD19 CAR T for the treatment of patients with relapsed/refractory non-Hodgkin lymphoma and chronic lymphocytic leukemia not previously exposed to autologous CAR T therapy.
DOI: 10.1200/jco.2026.44.16_suppl.70122026
Journal article
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter transformation
DOI: 10.1182/bloodadvances.20250179142026
Journal article
Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.
DOI: 10.1182/bloodadvances.20260200122026
Journal article
Structural Evaluation of RYR2-CPVT Missense Variants and Continuous Bayesian Estimates of Their Penetrance.
DOI: 10.1161/CIRCGEN.125.005457
RECENT SCHOLARLY WORKS
2026
Journal article
Impact of prior bendamustine exposure on bispecific antibody outcomes in relapsed/refractory follicular lymphoma
DOI: 10.1182/bloodadvances.20250185462026
Journal article
Biomarker Correlates of Clinical Outcomes from a Global phase 1b Study of JNJ-90014496, CD20/CD19 Bi-Specific Chimeric Antigen Receptor (CAR) T-cell Therapy for Patients with Large B-cell Lymphoma (LBCL)
DOI: 10.1016/j.jtct.2025.12.2252025
Journal article
High-throughput screens identify genotype-specific therapeutics for channelopathies.
DOI: 10.1172/jci.insight.191697